185 related articles for article (PubMed ID: 8475950)
21. [Gout nephropathy--ghost or reality?].
Huynh-Do U
Ther Umsch; 2004 Sep; 61(9):567-9. PubMed ID: 15493117
[TBL] [Abstract][Full Text] [Related]
22. CHRONIC LEAD NEPHROPATHY: THE DIAGNOSTIC USE OF CALCIUM EDTA AND THE ASSOCIATION WITH GOUT.
EMMERSON BT
Australas Ann Med; 1963 Nov; 12():310-24. PubMed ID: 14078907
[No Abstract] [Full Text] [Related]
23. Patterns of lead excretion in patients with gout and chronic renal failure--a comparative German and Australian study.
Craswell PW; Price J; Boyle PD; Behringer D; Stoeppler M; Ritz E
Sci Total Environ; 1987 Oct; 66():17-28. PubMed ID: 3120309
[TBL] [Abstract][Full Text] [Related]
24. The renal excretion of urate in chronic lead nephropathy.
Emmerson BT
Australas Ann Med; 1965 Nov; 14(4):295-303. PubMed ID: 5861252
[No Abstract] [Full Text] [Related]
25. [Chronic lead nephropathy. Epidemiology and diagnosis].
Clèdes J; Allain P
Presse Med; 1992 Apr; 21(16):759-62. PubMed ID: 1535133
[TBL] [Abstract][Full Text] [Related]
26. Detection and treatment of occupational lead nephropathy.
Wedeen RP; Malik DK; Batuman V
Arch Intern Med; 1979 Jan; 139(1):53-7. PubMed ID: 760684
[TBL] [Abstract][Full Text] [Related]
27. A retrospect on 25 years of lead research.
Goldberg A
Health Bull (Edinb); 1983 Sep; 41(5):270-4. PubMed ID: 6643047
[No Abstract] [Full Text] [Related]
28. [Lead nephropathy].
Gobbato F; Chiesura P
Minerva Nefrol; 1968; 15(1):12-24. PubMed ID: 5736446
[No Abstract] [Full Text] [Related]
29. Bone lead, hypertension, and lead nephropathy.
Wedeen RP
Environ Health Perspect; 1988 Jun; 78():57-60. PubMed ID: 3203647
[TBL] [Abstract][Full Text] [Related]
30. Nephropathy in chronic lead poisoning.
Morgan JM; Hartley MW; Miller RE
Arch Intern Med; 1966 Jul; 118(1):17-29. PubMed ID: 5940188
[No Abstract] [Full Text] [Related]
31. [THE KIDNEY IN CHRONIC LEAD POISONING].
RICHET G; ALBAHARY C; ARDAILLOU R; SULTAN C; MOREL-MAROGER A
Rev Fr Etud Clin Biol; 1964 Feb; 9():188-96. PubMed ID: 14139823
[No Abstract] [Full Text] [Related]
32. Chronic lead nephropathy in Queensland: alternative methods of diagnosis.
Craswell PW; Price J; Boyle PD; Heazlewood VJ; Baddeley H; Lloyd HM; Thomas BJ; Thomas BW; Williams GM
Aust N Z J Med; 1986 Feb; 16(1):11-9. PubMed ID: 3085647
[TBL] [Abstract][Full Text] [Related]
33. [Case of lead nephropathy due to chronic occupational lead exposure].
Ogata A; Sueta S; Tagawa M
Nihon Jinzo Gakkai Shi; 2011; 53(2):207-11. PubMed ID: 21516708
[TBL] [Abstract][Full Text] [Related]
34. Gout and crystal-related nephropathy.
Cameron JS; Simmonds HA
Contrib Nephrol; 1979; 16():147-53. PubMed ID: 467064
[No Abstract] [Full Text] [Related]
35. Experimental lead nephropathy: treatment with calcium disodium ethylenediaminetetraacetate.
Sánchez-Fructuoso AI; Blanco J; Cano M; Ortega L; Arroyo M; Fernández C; Prats D; Barrientos A
Am J Kidney Dis; 2002 Jul; 40(1):59-67. PubMed ID: 12087562
[TBL] [Abstract][Full Text] [Related]
36. Is lead chelation therapy effective for chronic kidney disease? A meta-analysis.
Yang SK; Xiao L; Song PA; Xu XX; Liu FY; Sun L
Nephrology (Carlton); 2014 Jan; 19(1):56-9. PubMed ID: 24341661
[TBL] [Abstract][Full Text] [Related]
37. Requiem for gouty nephropathy.
Beck LH
Kidney Int; 1986 Aug; 30(2):280-7. PubMed ID: 3761864
[No Abstract] [Full Text] [Related]
38. Contribution of lead to hypertension with renal impairment.
Batuman V; Landy E; Maesaka JK; Wedeen RP
N Engl J Med; 1983 Jul; 309(1):17-21. PubMed ID: 6406892
[TBL] [Abstract][Full Text] [Related]
39. [Temporary renal impairment during calcium EDTA treatment of lead poisoning].
BOERSMA MJ; BEYER T
Ned Tijdschr Geneeskd; 1960 Jun; 104():1152-4. PubMed ID: 13802058
[No Abstract] [Full Text] [Related]
40. Body burdens of lead in hypertensive nephropathy.
Osterloh JD; Selby JV; Bernard BP; Becker CE; Menke DJ; Tepper E; Ordonez JD; Behrens B
Arch Environ Health; 1989; 44(5):304-10. PubMed ID: 2510613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
